Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
QoL is a cool tool
L Procaccio, S Lonardi, F Loupakis, et al.
Italian Journal of Neurological Sciences
|
February 1, 1991
Lyme disease. First reported case in Sicily
R Rinaldi, A S Gabellini, L Procaccio, et al.
Recenti Progressi in Medicina
|
January 1, 1978
[Pancreatic cancer. Etiological and clinical considerations on 140 cases]
L Gullo, M Ventrucci, P L Costa, et al.
Minerva Anestesiologica
|
March 1, 1994
[Changes in the cell-mediated immune system in post-traumatic sepsis]
M Vinelli, F Ferrari, V Zanni, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale
|
February 3, 2006
Prognostic relevance of cell proliferation in major salivary gland carcinomas
M Vacchi Suzzi, A Alessi, C Bertarelli, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany
S Lonardi, K Potthoff, L Procaccio, et al.
Acta Europaea Fertilitatis
|
March 1, 1989
Epidemiological evaluation of the incidence of Chlamydia trachomatis infection in pregnancy
D Pungetti, M A Calderara, D Cantiero, et al.
ESMO Open
|
January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
M Reni, M Milella, F Bergamo, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
QoL is a cool tool
L Procaccio, S Lonardi, F Loupakis, et al.
Italian Journal of Neurological Sciences
|
February 1, 1991
Lyme disease. First reported case in Sicily
R Rinaldi, A S Gabellini, L Procaccio, et al.
Recenti Progressi in Medicina
|
January 1, 1978
[Pancreatic cancer. Etiological and clinical considerations on 140 cases]
L Gullo, M Ventrucci, P L Costa, et al.
Minerva Anestesiologica
|
March 1, 1994
[Changes in the cell-mediated immune system in post-traumatic sepsis]
M Vinelli, F Ferrari, V Zanni, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale
|
February 3, 2006
Prognostic relevance of cell proliferation in major salivary gland carcinomas
M Vacchi Suzzi, A Alessi, C Bertarelli, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany
S Lonardi, K Potthoff, L Procaccio, et al.
Acta Europaea Fertilitatis
|
March 1, 1989
Epidemiological evaluation of the incidence of Chlamydia trachomatis infection in pregnancy
D Pungetti, M A Calderara, D Cantiero, et al.
ESMO Open
|
January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
M Reni, M Milella, F Bergamo, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
Page
of 1